advertisement
Abstract #8918 Published in IGR 5-2
Laterality of the performance of glaucoma mass screening using frequency-doubling technology
Tatemichi M; Nakano T; Tanaka K; Hayashi T; Nawa T; Iwasaki A; Miyamoto T; Hiro H; Sugita MJournal of Glaucoma 2003; 12: 221-225
PURPOSE: This study investigated laterality during the performance of glaucoma mass screening with a frequency-doubling technology perimetry test. MATERIAL AND METHODS: A frequency-doubling technology screening mode (C-20-1, version 2.6) test was performed on both eyes of 14,784 persons. Subjects with visual field abnormalities detected by the frequency-doubling technology test or with fixation error underwent retesting without a specified interval for rest. Consequently, 206 subjects who fulfilled the screening criteria of the frequency-doubling technology-based glaucoma screening protocol (FDT-GSP(+)) were further investigated using the Humphrey visual field analyzer (30-2). As a result, 74 right eyes and 57 left eyes were shown to have definite glaucoma. RESULTS: Frequency-doubling technology data for the left eye demonstrated a significantly (p < 0.001) higher rate of artifacts, such as no reproducibility of results between the first and second tests (left/right: 2.4/1.7%) as well as fixation errors (left/right: 2.8/1.0%). The false-positive rate of the FDT-GSP for glaucoma was more than 1.5-fold higher in the left eye than in the right eye (16.3/9.8%). In the case that either eye exhibited FDT-GSP(+), the positive predictive value of the FDT-GSP for definite glaucoma in the left eye was almost half of that in the right eye (28.4 versus 53.8%). Specificity of the FDT-GSP for detection of definite glaucoma also exhibited a lower trend (p = 0.097) in the left eye (44.6%) than in the right eye (55.3%), but the sensitivity of the test was similar in both eyes (91.2 versus 90.5%, respectively). CONCLUSIONS: When frequency-doubling technology-based mass screening is performed on the general population, performance is lower for the left eye than for the right eye. This performance disparity is likely to be primarily associated with a difference in specificity.
Dr. M. Tatemichi, Department of Environmental and Occupational Health, Toho University School of Medicine, 5-21-16 Omori-nishi, Otaku, Tokyo 143-8540, Japan. tatemich@med.toho-u.ac.jp
Classification:
1.6 Prevention and screening (Part of: 1 General aspects)
6.6.3 Special methods (e.g. color, contrast, SWAP etc.) (Part of: 6 Clinical examination methods > 6.6 Visual field examination and other visual function tests)
